O1-9-1ARCHER 1050: first-line dacomitinib vs gefitinib for...

Annals of Oncology 2015 / 11 Vol. 26; Iss. suppl 7

O1-9-1ARCHER 1050: first-line dacomitinib vs gefitinib for advanced NSCLC in patients with EGFR activating mutation(s)

Nakagawa, Kazuhiko, Mok, Tony SK., Wu, Yi-Long, Rosell, Rafael, Tsuji, Fumito, Wang, Tao, Sbar, Eric
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv471.15
Date:
November, 2015
File:
PDF, 34 KB
english, 2015
Conversion to is in progress
Conversion to is failed